Fig. 4
From: Several circulating miRNAs related to hyperlipidemia and atherosclerotic cardiovascular diseases
miRNA-933 was significantly downregulated in patients with hyperlipidemia (n = 122) compared with healthy volunteers (n = 168) (Left); The expression of miRNA-933 in ASCVD group (n = 96) was also significantly lower than that in non-ASCVD group (n = 194) (Right). Expression levels are normalized to U6. P < 0.05 was considered statistically significant